Selected biotech news (3 May 1999)
PPL Therapeutics, the Edinburgh-based biotechnology company that developed Dolly the sheep, reported that losses grew to £14.2m in 1998 from £10.2m in the previous year. These continued losses come as PPL continues to inject money into research and drug development. The company's biggest hope is the production of the protein...